NurTHF: Nursing Teleconsultation for Patients With Heart Failure

Sponsor
University of Sao Paulo General Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05027399
Collaborator
(none)
60
1
2
1.1
55.3

Study Details

Study Description

Brief Summary

The incidence and prevalence of heart failure are increasing and represent a large portion of hospitalizations in Brazil, are also associated with high rates of morbidity, mortality and costs for the service of health. Such data, added to the current scenario of the pandemic caused by COVID-19, reveal the need for changes in clinical practice, so that health care is more effective and cost-effective and reaches patients without exposing them to risks. Thus, the application of nursing interventions through of telephone technology, which has strong evidence of effectiveness found in the literature, has become an alternative for the implementation of clinical interventions. Objective: Evaluate the effectiveness of nursing consultations performed remotely in improving quality of life and adherence to therapy of patients with HF due to cardiomyopathy of different etiologies. Method: The study will have as methodological framework the randomized clinical trial, with the recruitment of 60 volunteers with a diagnosis of chagasic HF, Hypertensive or Idiopathic, who are monitored at the outpatient clinic of Clinical Unit of Cardiomyopathies and Aortic Diseases or Clinical Unit of Hypertension, InCor-HCFMUSP, included by drawing lots into two groups. group A (n=30) will be monitored in biweekly nursing consultations by a period of three months added to the outpatient follow-up, and group B (n = 30) will follow the usual outpatient follow-up. Hypothesis: Patients HF carriers who periodically make telephone consultations of nursing have better quality of life and better therapeutic adherence when compared to patients who only have regular follow-up.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Nursing teleconsultation for lifestyle changes
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
After filtering this patient database, following the inclusion and exclusion criteria, will be performed randomization in two groups of 30 participants, randomization will be stratified by two variables, Age and Ejection Fraction, using the Jamovi statistical software. Group A will be composed of the participants who will have intervention, that is, the patients will receive fortnightly follow-up in nursing telephone consultation concurrently with follow-up usual outpatient clinic and group B (control) will be composed of the participants who will have no intervention and will continue to monitor according to the institution's routine.After filtering this patient database, following the inclusion and exclusion criteria, will be performed randomization in two groups of 30 participants, randomization will be stratified by two variables, Age and Ejection Fraction, using the Jamovi statistical software. Group A will be composed of the participants who will have intervention, that is, the patients will receive fortnightly follow-up in nursing telephone consultation concurrently with follow-up usual outpatient clinic and group B (control) will be composed of the participants who will have no intervention and will continue to monitor according to the institution's routine.
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Nursing Teleconsultation for Patients With Heart Failure Due to Hypersensitive, Chagasic or Idiopathic
Anticipated Study Start Date :
Oct 20, 2022
Anticipated Primary Completion Date :
Nov 20, 2022
Anticipated Study Completion Date :
Nov 22, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Intervention Group

Consultations will be carried out via video call, every 15 days for a period of 3 months, with a total of 6 telephone consultations that will have in order to clarify doubts about the CI, the monitoring of possible clinical signs of instability and help in adapting or creating strategies for better adherence to therapy.

Behavioral: Nursing teleconsultation for lifestyle changes
Guidance on better medication adherence, monitoring of signs and symptoms of exacerbation of heart failure, guidance on the need for fluid restriction.

No Intervention: Control Group

Will be composed by the participants who will have no intervention and will continue to monitor according to the institution's routine.

Outcome Measures

Primary Outcome Measures

  1. Improvement in the quality of life of patients who receive teleconsultations with a nurse [3 months]

    To analyze this result, the questionnaire Minnesota Living with Heart Failure Questionnaire (MLHFQ) validated in portuguese language will be used. Zero is the minimum value and 105 maximum value, The lower score, represents a better patient's quality of life.

  2. Improvement in the therapeutic adhesion of patients who receive teleconsultations with a nurse [3 months]

    To analyze this result, the questionnaire European Heart Failure Self-Care Behaviour Scale (EHFScBS) validated in portuguese language will be used. 12 is the minimum value and 60 maximum value, The lower score, represents a better self care.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients already registered in a database of the Clinical Unit of Cardiomyopathies and Aortic Diseases, InCor - HCFMUSP and Clinical Hypertension Unit - HCFMUSP, in outpatient follow-up for more than a year;

  • Stroke Volume < 40% and >25%

Exclusion Criteria:
  • Patientes with Pacemaker, Defibrillators, Implantable and Cardiac Resynchronization Therapy

  • Listed in heart transplant queue

  • Not having technological devices that allow the teleconsultation to be carried out

  • Psychic inability to understand the questionnaires and answer the questions asked by the interviewer

Contacts and Locations

Locations

Site City State Country Postal Code
1 Heart Institute (InCor), Hospital das Clinicas do HCFMUSP São Paulo Brazil

Sponsors and Collaborators

  • University of Sao Paulo General Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University of Sao Paulo General Hospital
ClinicalTrials.gov Identifier:
NCT05027399
Other Study ID Numbers:
  • Monitoring by teleconsultation
First Posted:
Aug 30, 2021
Last Update Posted:
Feb 4, 2022
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Sao Paulo General Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 4, 2022